● Recruiting

A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.

Condition: Chagas Disease · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants130

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersNo

About this study

This study is to investigate the ability of LXE408 to clear or reduce the level of parasites in the blood of people with chronic Chagas disease. Participants must have chronic Chagas disease without severe organ dysfunction.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (20)

Olive View UCLA Educ and Res Ins	Sylmar, California, United States	Recruiting
University of Florida Shands	Gainesville, Florida, United States	Recruiting
Boston Medical Center	Boston, Massachusetts, United States	Recruiting
Baylor College of Medicine	Houston, Texas, United States	Recruiting
Novartis Investigative Site	CABA, Buenos Aires, Argentina	Recruiting
Novartis Investigative Site	CABA, Buenos Aires, Argentina	Recruiting
Novartis Investigative Site	Córdoba, Córdoba Province, Argentina	Recruiting
Novartis Investigative Site	Caba, Argentina	Recruiting
Novartis Investigative Site	Corrientes, Argentina	Recruiting
Novartis Investigative Site	Formosa, Argentina	Recruiting
Novartis Investigative Site	Montes Claros, Minas Gerais, Brazil	Recruiting
Novartis Investigative Site	Recife, Pernambuco, Brazil	Recruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06632600